Mache dechanj, echanj stock jodi a
Stock quotes de 71229 konpayi nan tan reyèl.
Mache dechanj, echanj stock jodi a

Stock quotes

Stock quotes sou entènèt

Stock quotes istwa

Mache dechanj majiskil

Dividann Stock

Pwofi nan aksyon konpayi

Rapò finansye

Rating aksyon nan konpayi yo. Ki kote envesti lajan?

Northwest Biotherapeutics, Inc. bouchon mache

Volim nan komès stock Northwest Biotherapeutics, Inc. jodi a ak istwa a nan lèt majiskil nan Northwest Biotherapeutics, Inc. Depi nan kòmansman an nan komès nan NBYB.SG aksyon sou echanj la machandiz.
Add to widgets
Te ajoute nan widgets

Northwest Biotherapeutics, Inc. lèt majiskil

Jodi a lèt majiskil sou mache a nan Northwest Biotherapeutics, Inc. se 638 363 648 Euro.
+127 840 416 € (+25.04%)
chanjman nan lèt majiskil depi yè

Northwest Biotherapeutics, Inc. majiskil mete ajou yon fwa nan yon jounen. Sit entènèt nou an pran enfòmasyon nan lèt majiskil Northwest Biotherapeutics, Inc. pou jounen jodi a soti nan sous louvri. Baze sou komès nan stock stock Northwest Biotherapeutics, Inc. sou mache dechanj, ou ka evalye lèt majiskil nan Northwest Biotherapeutics, Inc.. Northwest Biotherapeutics, Inc. majiskil te ogmante pa $ 127 840 416.

Northwest Biotherapeutics, Inc. volim nan komès

Jodi a volim nan komès de aksyon Northwest Biotherapeutics, Inc. montan 100 Euro.
+100 € (+0%)
chanjman nan volim nan komès depi yè

Northwest Biotherapeutics, Inc. volim komès jodi a se 100 dola ameriken. Tablo komès chak jou a pou Northwest Biotherapeutics, Inc. se sou sit entènèt nou an. Northwest Biotherapeutics, Inc. komès nan tan reyèl hands sou pi echanj valè stock, sit entènèt nou an montre volim komès la chak jou nan Northwest Biotherapeutics, Inc.. Northwest Biotherapeutics, Inc. mache a ap monte.

Montre:
Pou

Northwest Biotherapeutics, Inc. mache bouchon tablo

Northwest Biotherapeutics, Inc. majiskil sou yon graf pa ane. Chanjman nan majiskil Northwest Biotherapeutics, Inc. pou chak mwa se 0%. Northwest Biotherapeutics, Inc. chanjman majiskil pou ane a se 33.52%. Jodi a, Northwest Biotherapeutics, Inc. majiskil estime nan 638 363 648 dola ameriken.

Semèn Mwa 3 mwa Ane 3 zan

Northwest Biotherapeutics, Inc. Istwa kapitalizasyon

Dat Kapitalizasyon
Kapitalizasyon (mache lèt majiskil) se valè sou mache a tout aksyon nan konpayi te fè kòmès sou echanj la machandiz. Mache lèt majiskil egal a pri de aksyon miltipliye pa kantite de aksyon eksepsyonèl.
04/05/2023 638 363 648 €
03/05/2023 510 523 232 €
02/05/2023 500 182 592 €
28/04/2023 453 520 192 €
27/04/2023 459 344 640 €
26/04/2023 478 107 360 €
25/04/2023 469 921 440 €

Northwest Biotherapeutics, Inc. tablo volim

Semèn Mwa 3 mwa Ane 3 zan

Northwest Biotherapeutics, Inc. done istwa volim

Dat Volim (24h)
Volim komèsyal de aksyon Northwest Biotherapeutics, Inc. se kantite total tout tranzaksyon ak aksyon NBYB.SG achte ak vann pandan dat la chwazi a.
04/05/2023 100 €
03/05/2023 0 €
02/05/2023 0 €
28/04/2023 0 €
27/04/2023 0 €
26/04/2023 0 €
25/04/2023 0 €

Sou 04/05/2023, Northwest Biotherapeutics, Inc. lèt majiskil mache a te $ 638 363 648. Sou 03/05/2023, Northwest Biotherapeutics, Inc. lèt majiskil mache a te $ 510 523 232. Northwest Biotherapeutics, Inc. majiskil egal a 500 182 592 dola ameriken nan 02/05/2023. Northwest Biotherapeutics, Inc. majiskil egal a 453 520 192 dola ameriken nan 28/04/2023.

Northwest Biotherapeutics, Inc. majiskil egal a 459 344 640 dola ameriken nan 27/04/2023. Northwest Biotherapeutics, Inc. lèt majiskil sou mache a se $ 478 107 360 nan 26/04/2023. Northwest Biotherapeutics, Inc. mache majiskil nan 25/04/2023 egal a 469 921 440 dola ameriken.

Lèt majiskil Northwest Biotherapeutics, Inc. jodi a se 638 363 648 €. Kapitalizasyon sou mache a nan Northwest Biotherapeutics, Inc. te chanje a +25.04% konpare ak yè. Volim komèsyal de aksyon NBYB.SG nan Northwest Biotherapeutics, Inc. nan dènye jou komès montan pou 100 €. Volim komèsyal de aksyon de Northwest Biotherapeutics, Inc. chanje pou +0% konpare ak jou komès anvan an.

Pri a de aksyon Northwest Biotherapeutics, Inc.

Finans Northwest Biotherapeutics, Inc.